Zobrazeno 1 - 10
of 7 791
pro vyhledávání: '"Adverse Drug Events"'
Publikováno v:
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, Vol 17, Iss 3, Pp 291-296 (2024)
Aim. The purpose of this work is to emphasize the importance and practical benefits of pharmacogenetics in medicine, demonstrating how the integration of pharmacogenetics into clinical practice can improve treatment outcomes and enhance the safety of
Externí odkaz:
https://doaj.org/article/b811d12900c1467f916385bc0d630c12
Autor:
Wesam S. Abdel-Razaq, Ghada Mardawi, Aiman A. Obaidat, Lama Aljahani, Maram Almutairi, Reham Almotiri, Nataleen A. Albekairy, Tariq Aldebasi, Abdulkareem M. Albekairy, Mohammad S. Shawaqfeh
Publikováno v:
Global Journal on Quality and Safety in Healthcare, Vol 7, Iss 4, Pp 175-181 (2024)
Introduction Prescribing errors (PEs) are the most common type of medication error, which may occur by prescribing the wrong medication, improper dose, dosage, and/or even prescribing a drug to the wrong patient. The present study aims to compile PEs
Externí odkaz:
https://doaj.org/article/2e2af084818d46bf8e4bfc9fb7dfe6fd
Publikováno v:
Thrombosis Journal, Vol 22, Iss 1, Pp 1-7 (2024)
Abstract Background Bleeding complications following intramuscular (IM) injections are generally considered rare with reported incidence of 0.06%. However, evidence on safety of IM injections among anticoagulated hospitalized patients is lacking. The
Externí odkaz:
https://doaj.org/article/070771dea38a43349b6104de071d8969
Publikováno v:
BMC Emergency Medicine, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The prevalence of emergency department (ED) visits among the elderly is high and increasing. While emergency services for the elderly involve many factors, drug-related problems (DRPs) that can worsen patient conditions are less f
Externí odkaz:
https://doaj.org/article/ba7e8a46582d4adabc47d5bb8298ebeb
Autor:
Vita Brisnik, Marietta Rottenkolber, Jochen Vukas, Miriam Schechner, Karoline Lukaschek, Caroline Jung-Sievers, Jochen Gensichen, Ulrich Thiem, Michael Drey, Nils Krüger, Alpana Mair, Bruce Guthrie, Sebastian Fischer, Tobias Dreischulte, for the POKAL Study Group
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background Antidepressants have a pivotal role in the treatment of many psychiatric disorders, but there are concerns about long-term use and adverse effects. The objectives of this study were (1) to examine time trends in antidepressant use
Externí odkaz:
https://doaj.org/article/d10660900662493395d6c30420463212
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 5, Pp 801-812 (2024)
Background/Aims Immune checkpoint inhibitors (ICIs) can induce immune-related adverse events, including endocrine dysfunctions, which can have serious consequences on patient health and quality of life. The clinical course and characteristics of immu
Externí odkaz:
https://doaj.org/article/dee5502e719a4f4681eb85c13a993394
Autor:
Beatrice Alex, Bruce Guthrie, Jinge Wu, Imane Guellil, Farah Francis, Aryo Pradipta Gema, Nidhaleddine Chenni, Yousra Berrachedi, Clare Llewellyn, Richard Tobin, Honghan Wu, Stella Arakelyan
Publikováno v:
NIHR Open Research, Vol 3 (2024)
Background Detecting Adverse Drug Events (ADEs) is an emerging research area, attracting great interest in the research community. Better anticipatory management of predisposing factors has considerable potential to improve outcomes. Automatic extrac
Externí odkaz:
https://doaj.org/article/e32bf2344dc04550b8fd34e905287c56
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundMedroxyprogesterone acetate (MPA), a synthetic progestogen, is extensively used for the treatment of various conditions, including contraception, irregular menstruation, functional uterine bleeding, and endometriosis. However, like all phar
Externí odkaz:
https://doaj.org/article/938a54d90d614f03947356c92108a7c5
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
ObjectiveHypertension is a leading global risk factor for disability and death. Irbesartan, a potent angiotensin II receptor blocker, requires continuous safety monitoring. We conducted a disproportionality analysis of irbesartan-related adverse drug
Externí odkaz:
https://doaj.org/article/e88796500f924bd09c83dbc07d1e37b1
Publikováno v:
Frontiers in Drug Safety and Regulation, Vol 4 (2024)
Electronic health records (EHRs) have emerged as resources for both the identification of adverse drug events (ADEs) and general population health surveillance, however questions remain around how best to utilize EHR data for drug safety signal ident
Externí odkaz:
https://doaj.org/article/8b86ed7aeb82437fba2d0273e12a669d